Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ph II Study of Perifosine Plus Gleevec for Patients With GIST

This study has been completed.
Sponsor:
Collaborator:
M.D. Anderson Cancer Center
Information provided by (Responsible Party):
AEterna Zentaris
ClinicalTrials.gov Identifier:
NCT00455559
First received: March 30, 2007
Last updated: February 14, 2014
Last verified: November 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2011
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
Publications:
Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 27, No 15S (May 20 Supplement), 2009: 10563